These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9724573)

  • 1. Effect of cilastatin on renal handling of vancomycin in rats.
    Kusama M; Yamamoto K; Yamada H; Kotaki H; Sato H; Iga T
    J Pharm Sci; 1998 Sep; 87(9):1173-6. PubMed ID: 9724573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nephrotoxicity and drug interaction of vancomycin].
    Toyoguchi T; Nakagawa Y; Watanabe H
    Nihon Yakurigaku Zasshi; 1996 Feb; 107(2):53-66. PubMed ID: 8721008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fosfomycin and imipenem/cilastatin on nephrotoxicity and renal excretion of vancomycin in rats.
    Nakamura T; Hashimoto Y; Kokuryo T; Inui KI
    Pharm Res; 1998 May; 15(5):734-8. PubMed ID: 9619782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of vancomycin and drug interaction study with cilastatin in rabbits.
    Toyoguchi T; Takahashi S; Hosoya J; Nakagawa Y; Watanabe H
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1985-90. PubMed ID: 9303398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
    Nakamura T; Kokuryo T; Hashimoto Y; Inui KI
    J Pharm Pharmacol; 1999 Feb; 51(2):227-32. PubMed ID: 10217324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
    Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
    Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
    Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
    Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between levofloxacin and vancomycin in rats--study of serum and organ levels.
    Mori H; Nakajima T; Nakayama A; Yamori M; Izushi F; Gomita Y
    Chemotherapy; 1998; 44(3):181-9. PubMed ID: 9612608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury.
    Dalaklioglu S; Tekcan M; Gungor NE; Celik-Ozenci C; Aksoy NH; Baykal A; Tasatargil A
    Toxicol Lett; 2010 Feb; 192(2):91-6. PubMed ID: 19833176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephrotoxicity and drug interaction of vancomycin (2)].
    Toyoguchi T; Nakagawa Y
    Nihon Yakurigaku Zasshi; 1996 May; 107(5):225-35. PubMed ID: 8690304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model.
    Cetin H; Olgar S; Oktem F; Ciris M; Uz E; Aslan C; Ozguner F
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1181-5. PubMed ID: 17880374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in nephrotoxicity of vancomycin administered once daily and twice daily in rats.
    Konishi H; Morita Y; Mizumura M; Iga I; Nagai K
    J Chemother; 2013 Oct; 25(5):273-8. PubMed ID: 24070134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vivo clearance study of vancomycin in rats.
    Nakamura T; Takano M; Yasuhara M; Inui K
    J Pharm Pharmacol; 1996 Nov; 48(11):1197-200. PubMed ID: 8961172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats.
    Nishino Y; Takemura S; Minamiyama Y; Hirohashi K; Ogino T; Inoue M; Okada S; Kinoshita H
    Free Radic Res; 2003 Apr; 37(4):373-9. PubMed ID: 12747731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failure.
    Hodoshima N; Masuda S; Inui K
    Drug Metab Pharmacokinet; 2007 Dec; 22(6):419-27. PubMed ID: 18159129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity.
    Humanes B; Jado JC; Camaño S; López-Parra V; Torres AM; Álvarez-Sala LA; Cercenado E; Tejedor A; Lázaro A
    Biomed Res Int; 2015; 2015():704382. PubMed ID: 26504822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of inactive ingredients against nephrotoxicity of vancomycin hydrochloride in rats.
    Hodoshima N; Nakano Y; Izumi M; Mitomi N; Nakamura Y; Aoki M; Gyobu A; Shibasaki S; Kurosawa T
    Drug Metab Pharmacokinet; 2004 Feb; 19(1):68-75. PubMed ID: 15499172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection.
    Humanes B; Camaño S; Lara JM; Sabbisetti V; González-Nicolás MÁ; Bonventre JV; Tejedor A; Lázaro A
    Nephrol Dial Transplant; 2017 Oct; 32(10):1645-1655. PubMed ID: 28340076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of tobramycin binding to rat renal brush border membrane by vancomycin.
    Yano Y; Hiraoka A; Oguma T
    J Pharmacol Exp Ther; 1995 Aug; 274(2):695-9. PubMed ID: 7636730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilastatin-insulin interaction in the rat.
    Tompkins GC; Brunner LJ; Luke DR
    Drug Metab Dispos; 1989; 17(1):54-7. PubMed ID: 2566470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.